Portfolio: Highlights

23andMe
Consumer-directed genetic testing for health, disease, and ancestry

Anthera Pharmaceuticals, Inc.
Cardiovascular and autoimmune drugs

Aratana Therapeutics, Inc
Leveraging human pharmaceutical drug development to develop innovative new medicines for animals

Conatus Pharmaceuticals
Development of innovative human therapeutics to treat liver disease and cancer

EKR Holdings, Inc.
Pain management and oncology products

Epizyme, Inc.
Second generation epigenetic drug discovery and development company

iPierian
Drug discovery and development company harnessing cellular reprogramming breakthroughs

Kalidex
Developing next-generation, broad-spectrum antibiotics for the treatment of serious infections

NeuroTherapeutics Pharma, Inc.
Developing therapies for diseases associated with central nervous system (CNS) hyper-excitability

Proteon Therapeutics
Renal and vascular disease therapies

Rhythm Pharmaceuticals
Developing peptide therapeutics that address unmet needs in metabolic diseases

TriVascular, Inc.
Novel endovascular repair devices to treat abdominal aortic aneurysms

Verastem
Novel drugs that selectively target cancer stem cells

BioMarin Pharmaceuticals
Biopharmaceuticals for serious diseases and medical conditions

Caliper Technologies Corp.
Cutting edge technologies for life science researchers.

Idenix Pharmaceuticals, Inc.
Anti-HIV and HBV therapy

Intercell AG
Vaccines for the prevention and treatment of infectious diseases.

Omrix Biopharmaceuticals, Inc.
Innovative biosurgical and passive immunotherapy products

Pacira Pharmaceuticals, Inc.
Sustained-release drug delivery technologies

Rigel
Novel small-molecule drugs for inflammatory/autoimmune diseases and cancer.

Alnara Pharmaceuticals
Acquired by Lilly

CoTherix
Acquired by Actelion

ForteBio, Inc.
Protein quantification and kinetics

HemoSense
Acquired by Inverness Medical Innovations

Hypnion
Acquired by Lilly

Idenix Pharmaceuticals, Inc.
Groundbreaking partnership with Novartis

IDUN Pharmaceuticals, Inc.
Early acquisition by Pfizer

Peplin
Acquired by LEO Pharma

Rinat Neuroscience Corp.
Genentech spinout acquired by Pfizer

Swedish Orphan BioVitrum
Acquired Swedish Orphan International Holding AB to create Swedish Orphan BioVitrum